Company News-Bio-Thera Solutions, Ltd.

2025-08-26

Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...

查看详情

08-252025

Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab

Guangzhou, China/Bad Vilbel, Germany –Bio-Thera will maintainresponsibility for development, manufacturing, and supply o...
07-162025

Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a Proposed Biosimilar to Simponi®

Guangzhou – July 16, 2025 – Bio-Thera Solutions, Ltd (688177:SH), a commercial-stagebiopharmaceutical company developing...
07-022025

IDMC Provides Positive Recommendation for Bio-Thera Solution’s BAT4406F (ADCC-Enhanced Anti-CD20 mAb) in Neuromyelitis Optica Spectrum Disorder Based on Interim Analysis of Pivotal Phase II/III Trial

Guangzhou,China – July 2025 – Bio-Thera Solutions, Inc. (688177:SH), a commercial-stagebiopharmaceutical company develop...